ASH NEWS ON MYELOPROLIFERATIVE DISORDERS

Drs. Verstovsek and Rafandi present data on Incyte’s JAK2 Inhibitor, INCB018424, currently being tested in MPD patients

Dr. Tefferi presents research on JAK2 germline and survival in MF patients

Favorable review of Cytopia by Mayo’s IRB and FDA for their JAK2 Inhibitor CYT387 trial now under way

SBIO to present data on their JAK2 Inhibitor SB1518, in Phase I

Please check back for updates